5 commercial payer policies list C88.9. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
5 policies from 2 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of C88.9 |
|---|---|---|
| Bortezomib Products | Feb 2, 2024 | Covered |
| Cerebral Perfusion Studies | Sep 14, 2023 | Covered |
| Double Balloon Enteroscopy | Feb 20, 2024 | Covered |
| Flow Cytometry, Ektacytometry, DNA Ploidy, and S-phase Fraction | Jun 5, 2023 | Covered |
| Policy | Effective | Status of C88.9 |
|---|---|---|
| Donor Lymphocyte Infusion for Hematologic Malignancies after Allogeneic Hematopoietic Progenitor Cell Transplantation | Jul 1, 2026 | Covered |